HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew D Lawrence Selected Research

Dopamine Agents (Dopaminergic Agents)

2/2013Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease.
5/2006Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew D Lawrence Research Topics

Disease

19Parkinson Disease (Parkinson's Disease)
01/2019 - 02/2003
5Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
12/2015 - 09/2009
3Gambling (Pathological Gambling)
01/2013 - 04/2010
2Cognitive Dysfunction
03/2016 - 12/2013
2Mania (Manias)
06/2011 - 04/2004
2Bulimia (Binge Eating)
04/2011 - 04/2010
1Dementia (Dementias)
03/2016
1Vomiting
03/2016
1Nausea
03/2016
1Obesity
10/2014
1Hyperphagia (Overeating)
10/2014
1Exanthema (Rash)
11/2011
1Mental Disorders (Mental Disorder)
11/2011
1Dyskinesias (Dyskinesia)
05/2010
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
04/2010
1Anemia
04/2008
1Substance-Related Disorders (Drug Abuse)
05/2006
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
04/2004
1Schizophrenia (Dementia Praecox)
02/2004
1Anorexia
02/2003

Drug/Important Bio-Agent (IBA)

16Dopamine (Intropin)FDA LinkGeneric
12/2015 - 02/2003
3RacloprideIBA
06/2015 - 02/2003
3Levodopa (L Dopa)FDA LinkGeneric
04/2011 - 04/2004
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2019 - 01/2019
2Cholinesterase Inhibitors (Anticholinesterases)IBA
03/2016 - 12/2013
2Cholinergic Agents (Cholinergics)IBA
03/2016 - 12/2013
2Rivastigmine (Exelon)FDA LinkGeneric
03/2016 - 12/2013
2Dopamine Agents (Dopaminergic Agents)IBA
02/2013 - 05/2006
1Dihydroxyphenylalanine (Dopa)IBA
01/2019
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
10/2014
1Aminobutyrates (Aminobutyric Acid)IBA
11/2011
1gamma-Aminobutyric Acid (GABA)IBA
11/2011
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2011
1Pharmaceutical PreparationsIBA
05/2010
1Dopamine Agonists (Dopamine Agonist)IBA
04/2010
1cobamamide (adenosylcobalamin)IBA
04/2008
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
04/2008
1Coenzymes (Enzyme Cofactors)IBA
04/2008
1fluorodopa F 18IBA
02/2004
1Dopamine D2 Receptor AntagonistsIBA
12/2003
1Sulpiride (neogama)IBA
12/2003

Therapy/Procedure

11Therapeutics
12/2015 - 10/2003
1Drug Therapy (Chemotherapy)
05/2010
1Deep Brain Stimulation
09/2009